Search results for "Bone diseases"

showing 10 items of 52 documents

Bone Mineral Density and Vitamin D Status in Female and Male Patients with Osteoarthritis of the Knee or Hip

2008

<i>Objective:</i> Osteoporosis (OP), osteoarthritis (OA) and vitamin D deficiency are age-related disorders. We investigated the association between bone mineral density (BMD), vitamin D and OA in patients undergoing total hip or knee replacements. <i>Method:</i> In total, 82 women and 35 men with mean ages of 70 and 68 years, respectively, were recruited for the study. The BMD of the lumbar spine and the proximal femur were measured by dual-energy X-ray absorptiometry. The vitamin D status was assessed by 25(OH)D levels, with a cut-off of ≤30 ng·ml<sup>–1</sup>. <i>Results:</i> In total, 84.7% of the patients had a vitamin D deficiency; 20% o…

AdultMalemedicine.medical_specialtyOsteoporosisOsteoarthritisOsteoarthritis Hipvitamin D deficiencyBody Mass IndexAbsorptiometry PhotonBone DensityInternal medicinemedicineVitamin D and neurologyHumansVitamin DAgedAged 80 and overBone mineralSex Characteristicsbusiness.industryAge FactorsMiddle AgedOsteoarthritis KneeVitamin D Deficiencymedicine.diseaseBone Diseases MetabolicEndocrinologyMale patientOsteoporosisFemaleSurgerybusinessEuropean Surgical Research
researchProduct

Risk of low bone mineral density and low body mass index in patients with non-celiac wheat-sensitivity: a prospective observation study.

2014

Background Non-celiac gluten sensitivity (NCGS) or ‘wheat sensitivity’ (NCWS) is included in the spectrum of gluten-related disorders. No data are available on the prevalence of low bone mass density (BMD) in NCWS. Our study aims to evaluate the prevalence of low BMD in NCWS patients and search for correlations with other clinical characteristics. Methods This prospective observation study included 75 NCWS patients (63 women; median age 36 years) with irritable bowel syndrome (IBS)-like symptoms, 65 IBS and 50 celiac controls. Patients were recruited at two Internal Medicine Departments. Elimination diet and double-blind placebo controlled (DBPC) wheat challenge proved the NCWS diagnosis. A…

AdultRiskmedicine.medical_specialtySettore MED/09 - Medicina InternaBone densityGlutensNon-celiac wheat sensitivityOsteoporosisGastroenterologyBody Mass IndexIrritable Bowel SyndromeYoung AdultDouble-Blind MethodBone DensityInternal medicineElimination dietmedicinePrevalenceHumansMultiple food allergyProspective StudiesProspective cohort studyIrritable bowel syndromeBone mineralMedicine(all)business.industryGeneral MedicineMiddle Agedmedicine.diseaseOsteopeniaBone Diseases MetabolicCeliac DiseaseIntestinal DiseasesEndocrinologyOsteoporosisnon-celiac wheat-sensitivityFemalebone mineral density; body mass index; non-celiac wheat-sensitivitybusinessbone mineral densityBody mass indexResearch ArticleBMC medicine
researchProduct

Depth of alveolar bone dehiscences in relation to gingival recessions.

1984

Dehiscence depths were measured in vivo during surgical treatment of 113 teeth with gingival recession in 27 subjects. The average dehiscence depth determined was 5.43 mm with an average recession depth of 2.67 mm. Statistical evidence of a correlation between recession depth and dehiscence depth (average distance between lowest point of recession and dehiscence = 2.8 mm) leaves 16 affected teeth (n = 113) with a distance of 4 mm or more (up to a maximum of 7.5 mm) between the gingival margin and the alveolar crest (facial) unaccounted for. The significance of these deviations from mean values in the etiology and prognosis of recessions is discussed.

Adultgenetic structuresmedia_common.quotation_subjecteducationDentistryDehiscenceRecessionAlveolar crestAlveolar ProcessMedicineHumansGingival RecessionSurgical treatmentGingival recessionDental alveolusmedia_commonbusiness.industryPrognosiseye diseasesGingival DiseasesPeriodonticssense organsmedicine.symptomBone DiseasesPeriodontal Indexbusinesshuman activitiesStatistical evidenceGingival marginJournal of clinical periodontology
researchProduct

Biomedical Applications of Polylactide (PLA) and Its Copolymers.

2018

n/a

Anti-Infective AgentPolyestersMicrofluidicsPolyesterPharmaceutical ScienceBiocompatible Materials02 engineering and technology01 natural sciencesAnalytical ChemistryPolymerizationlcsh:QD241-441Nanoparticlelcsh:Organic chemistryAnti-Infective AgentsDrug DiscoveryCopolymerHumansPhysical and Theoretical ChemistryDrug CarrierBiocompatible MaterialDrug CarriersPolymer scienceTissue Scaffolds010405 organic chemistryChemistryOrganic Chemistry021001 nanoscience & nanotechnologyBone Diseases Infectious0104 chemical sciencesBone Diseases Infectioun/aEditorialMicrofluidicChemistry (miscellaneous)PeptideMolecular MedicineNanoparticles0210 nano-technologyPeptidesHumanMolecules (Basel, Switzerland)
researchProduct

Sensory neuropathy with bone destruction due to a mutation in the membrane-shaping atlastin GTPase 3.

2014

Many neurodegenerative disorders present with sensory loss. In the group of hereditary sensory and autonomic neuropathies loss of nociception is one of the disease hallmarks. To determine underlying factors of sensory neurodegeneration we performed whole-exome sequencing in affected individuals with the disorder. In a family with sensory neuropathy with loss of pain perception and destruction of the pedal skeleton we report a missense mutation in a highly conserved amino acid residue of atlastin GTPase 3 (ATL3), an endoplasmic reticulum-shaping GTPase. The same mutation (p.Tyr192Cys) was identified in a second family with similar clinical outcome by screening a large cohort of 115 patients …

AtlastinAdultMaleIntracellular SpaceMutation MissenseSensory systemBiologymedicine.disease_causeEndoplasmic ReticulumGTP PhosphohydrolasesCohort StudiesFractures BoneYoung AdultmedicineMissense mutationHumansExomenociceptionAxonAge of OnsetHereditary Sensory and Autonomic NeuropathiesGenes DominantaxonGeneticsMutationEndoplasmic reticulumNeurodegenerationneurodegenerationmedicine.diseasePenetrancePedigreeHSANsensory neuronsmedicine.anatomical_structurePhenotypeCoughHaplotypesMutationGastroesophageal RefluxFemaleNeurology (clinical)Human medicineBone DiseasesNeuroscienceBrain : a journal of neurology
researchProduct

Do we need to change the guideline values for determining low bone mineral density in athletes? [Viewpoint]

2022

Bone Diseases MetabolicAbsorptiometry Photon:Medisinske Fag: 700::Idrettsmedisinske fag: 850 [VDP]AthletesBone DensityPhysiologyPhysiology (medical)HumansVDP::Medisinske Fag: 700::Idrettsmedisinske fag: 850
researchProduct

Distribution of Cartilage Proteoglycan (Aggrecan) Core Protein and Link Protein Gene Expression during Human Skeletal Development

1991

The distribution of cartilage proteoglycan core protein (aggrecan) and cartilage proteoglycan link protein was investigated by in situ hybridization during different stages of human skeletal development. Aggrecan and link protein expression were confined to chondrocytes of the developing skeleton and other cartilaginous structures. Distribution and intensity of the signal was identical with aggrecan as compared to link protein probes. Parallel to the calcification of cartilaginous matrix, chondrocytes of this area lost the expression of aggrecan and link protein specific mRNA and stayed negative throughout the following stages of skeletal development. Highest expression was found in the low…

Bone and BonesChondrocyteRNA ComplementaryPseudoachondroplasiaRheumatologyGene expressionmedicineHumansLectins C-TypeRNA AntisenseAggrecansAggrecanExtracellular Matrix ProteinsMessenger RNABone DevelopmentbiologyCartilageBinding proteinInfant NewbornNucleic Acid HybridizationProteinsDNAmusculoskeletal systemmedicine.diseaseMolecular biologycarbohydrates (lipids)Bone Diseases MetabolicCartilagemedicine.anatomical_structureGene Expression RegulationProteoglycanProtein Biosynthesisbiology.proteinRNAProteoglycansMatrix
researchProduct

Short time guided bone regeneration using beta-tricalcium phosphate with and without fibronectin. An experimental study in rats

2020

Background  The aim of this histomorphometric study was to assess the bone regeneration potential of beta-tricalcium phosphate with fibronectin (β-TCP-Fn) in critical-sized defects (CSDs) in rats calvarial, to know whether Fn improves the new bone formation in a short time scope. Material and Methods  CSDs were created in 30 Sprague Dawley rats, and divided into four groups (2 or 6 weeks of healing) and type of filling (β-TCP-Fn, β-TCP, empty control). Variables studied were augmented area (AA), gained tissue (GT), mineralized/non mineralized bone matrix (MBM/NMT) and bone substitute (BS). Results 60 samples at 2 and six weeks were evaluated. AA was higher for treatment groups comparing to …

Calcium Phosphatesmedicine.medical_specialtyBone RegenerationBone substituteRats as laboratory animalsBone matrixRats Sprague-Dawley03 medical and health sciences0302 clinical medicineBeta-tricalcium phosphateInternal medicinemedicineSprague dawley ratsAnimalsBone formationBone regenerationGeneral DentistryRates (Animals de laboratori)biologyChemistryRegeneració (Biologia)Regeneration (biology)ResearchSkull030206 dentistry:CIENCIAS MÉDICAS [UNESCO]FibronectinsRatsFibronectinRegeneration (Biology)EndocrinologyMalalties dels ossosOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASbiology.proteinSurgeryImplantologyBone diseases
researchProduct

Health status of young children with cancer following discontinuation of therapy.

1987

This paper reports late effects and health status of 198 children who had cancer or leukemia diagnosed under 2 years of age and their therapies electively withdrawn. This series (92 neuroblastoma (NBL), 57 Wilms' tumor (WT), 46 acute lymphoblastic leukemia (ALL), and 3 non-Hodgkin's lymphoma) was followed for 1-12 years after discontinuation of therapy. Thirty-three children were diagnosed before 1973, 92 between 1973 and 1977, and 73 after 1977 in 16 Italian Pediatric Oncology Centers. As of December 1983, 176 children were reported to be alive and without evidence of primary cancer by physicians responsible for their care. One child died from a second primary tumor, two from late recurren…

Cancer Researchmedicine.medical_specialtyPediatricsmedicine.medical_treatmentAntineoplastic AgentsGrowthNeoplasms Multiple PrimaryLeukoencephalopathyMuscular DiseasesNeoplasmsAcute lymphocytic leukemiamedicineHumansKyphoscoliosisChemotherapyRadiotherapybusiness.industryInfantCancerSequelamedicine.diseaseLeukemia LymphoidDiscontinuationSurgeryRadiation therapyOncologyChild PreschoolPediatrics Perinatology and Child HealthBone DiseasesNeoplasm Recurrence LocalNervous System DiseasesbusinessFollow-Up Studies
researchProduct

Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity?

2022

Abstract Background In persons living with HIV (PLWH), the burden of non-communicable chronic diseases increased over time, because of aging associated with chronic inflammation, systemic immune activation, and long-term exposure to the combination antiretroviral therapy (ART). Methods To explore the association of chronological age, age at first ART, and exposure to ART with non-communicable chronic diseases, we performed a cross-sectional analysis to evaluate the prevalence of comorbidities in patients enrolled in the SCOLTA Project, stratified by groups of chronological age (50–59 and 60–69 years) and by years of antiretroviral treatment (ART, ≤ 3 or > 3 years). Results In 1394 subjec…

Cross-Sectional StudieMaleART exposureHIVMultimorbidityHIV InfectionsComorbidityOsteoporosis.Noncommunicable DiseaseBone Diseases MetabolicCross-Sectional StudiesInfectious DiseasesAgeAnti-Retroviral AgentsHypertensionHumansOsteoporosisAnti-Retroviral AgentFemaleHIV InfectionNoncommunicable DiseasesAgedHuman
researchProduct